Skip to content
Screener

Werewolf Therapeutics, Inc. HOWL Q1 2026 earnings

Reported May 7, 2026 · Before market open

EPS-$0.28Beat by $0.04
EPS estimate-$0.32

Next report

Nov 3, 2026 (in 3 months)
Revenue estimate$18.3M
EPS estimate-$0.22

FAQ

When did Werewolf Therapeutics, Inc. report Q1 2026 earnings?
Werewolf Therapeutics, Inc. (HOWL) reported Q1 2026 earnings on May 7, 2026 before market open.
What were Werewolf Therapeutics, Inc.'s Q1 2026 revenue and EPS?
Werewolf Therapeutics, Inc. reported eps of $-0.28 for Q1 2026.
Did Werewolf Therapeutics, Inc. beat estimates in Q1 2026?
EPS beat the consensus estimate of $-0.32 by $0.04.
How did Werewolf Therapeutics, Inc.'s Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 30.0% from $-0.40.
Where can I find Werewolf Therapeutics, Inc.'s Q1 2026 SEC filings?
You can read the 8-K earnings release (0001785530-26-000011) and the 10-Q periodic report (0001785530-26-000012) directly on SEC EDGAR. The filing index links above go to sec.gov.